SGLT2i: therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Jiajia Wu, Hong Cai, Jia Xia, Tianyi Zhang, Jiayi Yan, Xinhua Shao, Amanda Ying Wang*, Jianxiao Shen*, Shan Mou

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

14 Downloads (Pure)
Original languageEnglish
Article number106883
Pages (from-to)1-4
Number of pages4
JournalPharmacological Research
Publication statusPublished - Sept 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.


  • Contrast induced acute kidney injury (CI-AKI)
  • Non-diabetes
  • Predisposing factors
  • Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
  • Treatment measures

Cite this